close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ:CDIO)

1.190 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 Next >
News headline image
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
News headline image
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
By Jeremy Golden, Benzinga 
Via TheNewswire.com
News headline image
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
By Jeremy Golden, Benzinga 
Via TheNewswire.com
News headline image
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc’s Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes
From Cardio Diagnostics Holdings
Via Business Wire
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
News headline image
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
By Jeremy Golden, Benzinga 
Via TheNewswire.com
News headline image
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence Death
News headline image
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
From Cardio Diagnostics Holdings, Inc
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
From Cardio Diagnostics Holdings, Inc
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins
From Cardio Diagnostics Holdings, Inc
Via Business Wire
News headline image
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
From Cardio Diagnostics Holdings, Inc
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
From Cardio Diagnostics Holdings, Inc
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study
From Cardio Diagnostics Holdings, Inc
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today